US 11,937,809 B2
Tissue ingrowth materials and method of using the same
Frederick E. Shelton, IV, Hillsboro, OH (US); and Tamara S. V. Widenhouse, Clarksville, OH (US)
Assigned to Cilag GmbH International, Zug (CH)
Filed by Cilag GmbH International, Zug (CH)
Filed on May 31, 2022, as Appl. No. 17/828,261.
Application 17/828,261 is a continuation of application No. 17/081,222, filed on Oct. 27, 2020, granted, now 11,564,680.
Application 17/081,222 is a continuation of application No. 16/296,977, filed on Mar. 8, 2019, granted, now 11,219,451, issued on Jan. 11, 2022.
Application 16/296,977 is a continuation of application No. 15/645,293, filed on Jul. 10, 2017, granted, now 10,285,691, issued on May 14, 2019.
Application 15/645,293 is a continuation of application No. 14/075,459, filed on Nov. 8, 2013, granted, now 9,700,311, issued on Jul. 11, 2017.
Prior Publication US 2022/0287710 A1, Sep. 15, 2022
Int. Cl. A61B 17/072 (2006.01); A61B 17/068 (2006.01); A61B 17/00 (2006.01); A61B 17/115 (2006.01)
CPC A61B 17/068 (2013.01) [A61B 17/072 (2013.01); A61B 17/07207 (2013.01); A61B 17/07292 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/0046 (2013.01); A61B 2017/00893 (2013.01); A61B 2017/00898 (2013.01); A61B 2017/00938 (2013.01); A61B 2017/00942 (2013.01); A61B 2017/07214 (2013.01); A61B 17/115 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A surgical stapling adjunct material, comprising:
a hybrid adjunct material releasably retained on a cartridge or anvil body configured to compress when a compressive force is applied thereto and to provide a spring back force when compressive force is removed, the hybrid adjunct material having a net ionic charge,
wherein the hybrid adjunct material includes a biologic material layer and a synthetic material layer, and
wherein the synthetic material layer is at least partially permeable and configured to allow one or more components of the biologic layer to pass therethrough.